MULTIPLE SCLEROSIS

This study tested whether clemastine fumarate, an antihistamine, could improve eye movement in people with multiple sclerosis (MS) who have a specific eye coordination problem called internuclear ophthalmoparesis (INO). The trial planned to enroll 80 adults with MS and INO, givin…

This study aimed to see if the drug alemtuzumab could help children aged 10 to 17 with relapsing-remitting multiple sclerosis (MS) whose disease was still active despite other treatments. Researchers planned to measure brain lesions and safety, but the study was stopped early aft…

This study tested an experimental oral drug (SAR443820) in 174 adults with multiple sclerosis (MS) to see if it could lower a marker of nerve damage in the blood. The study was stopped early because the drug did not show a clear benefit compared to a placebo. Participants were fo…

This study tested a device called the Dysphagia Detection System (DDS) to see if it could accurately detect swallowing problems in people with conditions like stroke, Parkinson's disease, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray te…

This study tested a special hand therapy program for people with multiple sclerosis who have trouble with feeling in their hands. The goal was to see if the therapy could improve hand function and quality of life. The study was stopped early and only included 10 participants, so …

This study aimed to see if the drug ozanimod could help reduce fatigue in people with multiple sclerosis (MS). Researchers planned to track 26 adults with MS over three months using fatigue questionnaires and brain scans. The study was terminated early, so results are limited.

This early-stage study tested whether a single dose of bryostatin is safe for people with multiple sclerosis who are already taking standard treatments. Only 4 participants were enrolled before the study was stopped. The main goal was to track side effects, not to measure if the …

This study aimed to see if measuring certain proteins on immune cells could predict whether multiple sclerosis (MS) patients would have a relapse or a severe "rebound" after stopping the drug ozanimod. Researchers planned to follow 23 adults with relapsing-remitting MS, taking bl…

This study looked at whether special MRI scans can detect early changes in the brains of people with multiple sclerosis (MS) who are taking the drug Tysabri. Researchers planned to follow 70 adults with relapsing-remitting MS for two years. The goal was to find MRI patterns that …

This study tested a wearable device called Syde® to see if it can track movement changes in people with multiple sclerosis (MS). Researchers compared data from the device with standard clinic tests like walking speed and disability scores. The goal was to see if the device could …